Profile of Asfotase Alfa in the Treatment of Hypophosphatasia: Design, Development, and Place in Therapy

softbones October 28, 2020

0 Comments

To read more please click on the link below.
Read Article

Categories: Scientific Publications

Tags: alkaline phosphatase, asfotase alfa, Biomarkers, bone, enzymopathy, Inborn error of metabolism, inorganic pyrophosphate, mineralization, pyridoxal phosphate, Rickets, Vitamin B6

Meet Blynda Kellner

Meet Blynda Kellner Relationship to HPP: I was diagnosed with HPP around 6 months old. Joined: I found Soft Bones, I think in 2015. I’m…

Margaret Robb August 12, 2024

0 Comments

Effects of asfotase alfa in adults with pediatric-onset hypophosphatasia over 24 months of treatment

To read more please click on the link below. Read Article

Margaret Robb November 22, 2023

0 Comments

Isabella and Julia

They are identical mirror twins who overcame all odds to survive their arrival. Isabella & Julia were born at 35 weeks and 6 days. Brought…

Taralyn Naslonski November 6, 2020

0 Comments

Safety profile of asfotase alfa treatment of patients with hypophosphatasia: a pooled analysis

To read more please click on the link below. Read Article

softbones October 28, 2020

0 Comments

Five-Year Efficacy and Safety of Asfotase Alfa Therapy for Adults and Adolescents with Hypophosphatasia

To read more please click on the link below. Read Article

softbones October 28, 2020

0 Comments

Responses

You must be logged in to post a comment.

Mail Address
The US Hypophosphatasia Foundation
141 Hawkins Place, #267
Boonton, NJ 07005, USA.

Organization

Programs

Community

Office Address
1719 NJ-10, Suite 315
Parsippany, NJ 07054

Follow Us on Social Media!

Disclaimer: This Website is owned by Soft Bones, Inc. All materials contained in this Website (the “Materials”) are either owned by or licensed to us and are protected by intellectual property and other laws. We retain all proprietary rights to the Materials. This Website is copyrighted. All rights are reserved. Except as expressly authorized by us, any use, copy, reproduction, display, performance, modification or retransmission of the Materials is strictly prohibited.

Related Articles

Responses